Answers are grounded in this paper and cite their sources.
Coronary artery disease (CAD) is a clinical manifestation of atherosclerosis in the arteries supplying myocardium. Inflammation is the cornerstone in the development and progression of atherosclerosis. Amongst the various biomolecules tumour necrosis factor-α (TNF-α), interleukin-18 (IL-18) and interleukin-1β (IL-1β) build an inflammatory bionetwork in developing the disease. In this study we investigated the association of TNF-α SNPs [-308G/A (rs1800629), -1031T/C (rs1799964), -863C/A (rs1800630)]; IL-18 [-137G/C (rs187238)] and IL-1β SNPs [+3954C/T (rs1143634), -31C/T (rs1143627), and -511C/T (rs16944)] with coronary artery disease risk in Kashmiri population. A total of 200 cases and 260 controls were recruited in the study. Logistic regression analysis was done to investigate the association between SNPs and CAD risk. In case of TNF-α, the -308G/A-A/A and -863A/A showed an association with disease while -1031T/C was found to have an inverse relation. The IL-18-137G/C showed no statistically significant difference between controls and cases. For IL-1β the +3954C/T and -31C/T SNP variants showed no disease association while -511T/T showed significant association. Haplotypic analysis revealed the haplotype ATCGCC and GTACCTC to be associated with CAD risk and GTCGTTT, in particular, showing a profound association. Overall, our study suggests that TNF-α and IL-1β promoter polymorphisms may act as genetic risk factors in developing the coronary artery disease.
No takes yet. Share an insight, caveat, or question.
Khan et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: